Legal Peptide Therapy and Integrative Chiropractic Care in El Paso

Abstract

Peptide therapy is becoming an important topic in integrative medicine, metabolic health, weight management, hormone care, and physical recovery. However, not every peptide sold online or discussed on social media is FDA-approved or appropriate for medical treatment. Legal peptide use depends on the specific medication, its FDA status, how it is prescribed or compounded, the patient’s medical needs, and federal and state laws.

At ChiroMed – Integrated Medicine in El Paso, Texas, an integrative model can bring medical evaluation, nurse practitioner services, chiropractic care, functional medicine, nutrition, and rehabilitation together. Medical providers handle evaluation and prescription decisions within their professional authority, while chiropractic care focuses on biomechanics, joint function, movement, strength, and musculoskeletal rehabilitation. This article explains how these roles can work together while keeping peptide treatment patient-centered, medically appropriate, and within professional scope.

What Is Legal Peptide Therapy?

Peptides are short chains of amino acids. Amino acids are the building blocks of proteins, and many naturally occurring peptides act as signals inside the body.

Some peptide-based medicines have established medical uses. Others remain experimental or have limited evidence in people.

The important question is not simply, “Are peptides legal?”

A better question is:

Is this specific peptide legally available and medically appropriate for this particular patient, from this particular source, and for this particular use?

Legal medical use can include several different situations:

• An FDA-approved peptide-based drug used for an approved indication
• An FDA-approved medication prescribed for a medically appropriate off-label use
• A compounded medication prepared under applicable federal and state requirements
• An investigational drug being used through an authorized research pathway

These categories are not interchangeable.

The FDA makes an especially important distinction regarding compounded medications. Compounded medications can serve a medical need for certain patients, but they are not FDA-approved. The FDA does not review each compounded medication for safety, effectiveness, or manufacturing quality before it reaches the patient (U.S. Food and Drug Administration [FDA], 2026a).

Why “Research Peptides” Are Different

Patients may see peptides advertised online with labels such as:

• “Research use only”
• “Not for human consumption”
• “Laboratory use only”

These labels should not be confused with an FDA-approved prescription medication or a lawfully prepared compounded prescription.

The fact that a chemical can be purchased through a website does not establish that it is approved or appropriate for human treatment.

This is especially important because peptide regulation continues to change. Different substances may have different FDA classifications, compounding restrictions, safety concerns, and available evidence.

Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, the FDA limits which bulk drug substances may be used. These lists and regulatory policies can change as new evidence becomes available (FDA, 2026b).

For this reason, healthcare professionals should evaluate the current regulatory status of the specific peptide rather than assuming that all peptides fall into the same category.

Compounded Peptides Require Special Attention

Compounding can be valuable when a commercially available FDA-approved medication cannot meet a patient’s individual medical need.

For example, a patient might need a different dosage form because of an allergy or another clinical concern.

However, compounding does not automatically make a peptide legal, FDA-approved, or appropriate.

Under federal rules, Section 503A compounders face requirements about which bulk substances they may use. Section 503B outsourcing facilities also operate under specific limits regarding bulk substances and drug shortages (FDA, 2026b).

Patients should understand an important difference:

An FDA-approved medication and a compounded version of a medication are not the same regulatory product.

The FDA states that compounded drugs have not gone through FDA premarket approval for safety, effectiveness, and quality (FDA, 2026a).

This makes pharmacy selection, clinical justification, documentation, dosing, patient education, and follow-up especially important.

What the New Mexico Board of Nursing Says

The September 2026 New Mexico Board of Nursing Peptide Therapies FAQ provides a useful example of how one state nursing board is approaching this rapidly changing field.

The Board emphasizes that its FAQ provides general interpretation only. It specifically states that the document is not a legal opinion and cannot be cited as legal authority.

The guidance states that APRNs prescribing compounded medications should remain within their education, experience, population focus, and prescriptive authority. It also emphasizes a valid provider-patient relationship, appropriate history and physical examination, clinical justification, informed consent, monitoring, and documentation.

The Board also recommends that clinicians:

• Make sure compounding is legally permitted
• Use appropriately licensed pharmacies
• Explain when a patient is receiving a compounded medication
• Document the reason for using the compounded product
• Avoid questionable or unverified sources

The New Mexico guidance is useful for understanding professional safety principles, but ChiroMed is located in Texas. Therefore, Texas law and Texas professional licensing requirements govern care delivered in Texas.

Chiropractic and Medical Roles Must Remain Clear in Texas

ChiroMed describes itself as an integrated healthcare practice bringing chiropractic care, nurse practitioner services, rehabilitation, nutrition, and other healthcare disciplines together in one setting.

Clear professional roles are important in this type of practice.

Under Texas Occupations Code §201.002, chiropractic practice includes evaluation of the biomechanical condition of the spine and musculoskeletal system and nonsurgical, noninvasive procedures intended to improve musculoskeletal biomechanics.

The same law states that chiropractic practice does not include prescribing controlled substances, dangerous drugs, or other prescription drugs.

Therefore, a clinician cannot prescribe peptides under a Texas chiropractic license alone.

This distinction is especially important for a clinician such as Dr. Alexander Jimenez, DC, APRN, FNP-BC, who holds both chiropractic and advanced practice nursing credentials.

His chiropractic license supports chiropractic and musculoskeletal care. Medical evaluation and prescription decisions must be performed under the appropriate APRN authority and applicable Texas rules.

The Nurse Practitioner’s Role in Peptide Therapy

Texas APRNs who prescribe medications must meet Texas requirements for prescriptive authority.

Texas law allows qualified APRNs and physicians to enter into prescriptive authority agreements. These agreements define the practice setting, medication categories, consultation, communication, quality assurance, and referral processes.

This makes the medical side of peptide therapy different from chiropractic treatment.

Depending on the patient’s needs, the medical evaluation may include:

• Medical history
• Current medications and supplements
• Physical examination
• Laboratory testing
• Contraindications and risk factors
• Diagnosis
• Treatment alternatives
• Medication selection
• Informed consent
• Follow-up laboratory testing
• Response to treatment
• Side-effect monitoring

Do not select a peptide simply because it is popular.

The patient’s diagnosis, health history, goals, risks, available evidence, and legal treatment options should guide the medical decision.

ChiroMed’s Multidisciplinary Model

At ChiroMed – Integrated Medicine, the goal is to bring different parts of healthcare together rather than treating each problem in isolation.

ChiroMed describes its services as including chiropractic care, nurse practitioner services, rehabilitation, nutrition, and integrative approaches for patients with musculoskeletal, injury, chronic pain, and wellness concerns.

The multidisciplinary team also includes Dr. Maria Guadalupe Cardenas, MD, whom ChiroMed identifies as a board-certified internal medicine physician, Medical Director, and Collaborative Physician with more than four decades of experience.

Public NPI information lists Dr. Maria Guadalupe Cardenas as an internal medicine physician in El Paso with NPI 1164426748 and Texas medical license J2933.

Within this model, Dr. Cardenas provides medical direction and internal medicine experience alongside Dr. Jimenez’s work in advanced practice nursing, chiropractic care, functional medicine, injury management, and rehabilitation.

The goal is coordinated care, while each clinician works within the appropriate professional scope.

How Chiropractic Care Can Complement Peptide Treatment

Chiropractic treatment should not be promoted as making a peptide medication more powerful.

Instead, these treatments may address different parts of a patient’s overall health and recovery.

A medically managed therapy may address a specific metabolic, hormonal, or medical problem.

Chiropractic and rehabilitation care can focus on the patient’s ability to move and function.

At ChiroMed, integrative chiropractic care may support:

• Joint mobility
• Spinal biomechanics
• Range of motion
• Posture
• Muscle balance
• Functional strength
• Neuromuscular coordination
• Progressive exercise
• Return to normal activities
• Injury rehabilitation

ChiroMed’s published clinical model emphasizes connecting medical evaluation with chiropractic care and rehabilitation rather than replacing one healthcare profession with another.

This can be particularly useful when a patient has both a medical concern and a musculoskeletal limitation.

For example, a patient receiving medical weight-management treatment may need help maintaining muscle mass, increasing activity, and improving physical function.

Strength and Muscle Preservation Matter

Muscle health deserves special attention during some medical weight-management programs.

The New Mexico Board of Nursing guidance recommends attention to:

• Adequate protein
• Resistance exercise
• Preservation of lean body mass
• Vitamin and nutrient intake
• Long-term lifestyle changes

Rehabilitation and integrative chiropractic care may fit naturally into a broader treatment plan.

A patient with back pain, knee pain, poor mobility, or an old injury may find exercise difficult. Treating mechanical barriers and developing a progressive rehabilitation program may help that person become more physically active.

The goal is not simply weight loss.

It is to help patients maintain:

strength + mobility + muscle + function.

Clinical Observations From Dr. Alexander Jimenez

In his clinical writings, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, describes health and recovery through a systems-based approach.

Instead of relying on one treatment, his clinical model connects areas such as:

• Chiropractic biomechanics
• Functional medicine
• Nutrition
• Musculoskeletal rehabilitation
• Laboratory findings when appropriate
• Strength and conditioning
• Injury recovery
• Medical evaluation
• Lifestyle modification

This philosophy is also reflected throughout ChiroMed’s published material, which describes integrated injury care as a combination of medical evaluation, chiropractic care, functional medicine, rehabilitation, and other supportive options.

Peptide treatment, when medically appropriate and legally available, can therefore be one part of a larger care plan, not a replacement for good nutrition, exercise, rehabilitation, sleep, or medical monitoring.

A Patient-Centered Approach to Peptide Therapy

Responsible peptide treatment should begin with the patient—not with a product.

Before considering treatment, the healthcare team should determine:

• What problem is being treated?
• Is there an established diagnosis?
• Is the medication FDA-approved?
• If it is compounded, why is compounding medically appropriate?
• Is there reasonable evidence supporting its use?
• What are the risks and alternatives?
• Does the patient’s medical history create contraindications?
• What monitoring will be needed?
• Who is responsible for prescribing and follow-up?
• Is the pharmacy properly licensed?
• Is the treatment permitted under current federal and state requirements?

The New Mexico Board’s guidance similarly emphasizes history, examination, laboratory testing when indicated, informed consent, documentation, treatment response, adverse effects, and follow-up.

Integrating Medicine, Movement, and Recovery at ChiroMed

The future of integrative healthcare is not about one profession trying to perform every type of treatment.

It is about different professionals contributing their expertise to the same patient.

At ChiroMed – Integrated Medicine in El Paso, chiropractic care can address biomechanics, movement, spinal and joint health, physical strength, and rehabilitation. Advanced practice nursing can provide appropriate medical evaluation and treatment within APRN scope and Texas prescriptive authority. Internal medicine leadership can add another layer of medical direction and clinical coordination.

Nutrition, functional medicine, personal injury care, and rehabilitation can then support the patient’s larger goals.

This creates a practical model:

Medical care addresses medical needs.
Chiropractic care addresses biomechanics and musculoskeletal function.
Rehabilitation develops strength and movement.
Nutrition provides the building blocks for recovery.
Medical oversight helps keep the entire plan appropriate and coordinated.

Peptide science will continue to change. Some peptide-based medications already have established medical roles, while other substances remain investigational, restricted, or supported by limited human evidence.

For patients and clinicians alike, the safest approach is to focus on evidence, professional scope, current regulations, appropriate medical evaluation, legitimate pharmacy sources, and careful follow-up.

At ChiroMed, integrated care means looking beyond one medication or one adjustment and building a treatment plan around the health and functional needs of the whole person.

---

References

ChiroMed – Integrated Medicine. (2026a). Integrated medicine services in El Paso, Texas.

ChiroMed – Integrated Medicine. (2026b). ChiroMed – Integrated Medicine: Holistic healthcare in El Paso, TX.

ChiroMed – Integrated Medicine. (2026c). Integrated injury care in El Paso, TX.

ChiroMed – Integrated Medicine. (2026d). Peptide therapy, nutrition, and integrative chiropractic care.

Food and Drug Administration. (2026a). Compounding and the FDA: Questions and answers.

Food and Drug Administration. (2026b). Bulk drug substances used in compounding under Section 503A of the FD&C Act.

Food and Drug Administration. (2026c). Human drug compounding.

Jimenez, A. (2026). Peptide therapy, nutrition, and chiropractic care explained.

New Mexico Board of Nursing. (2026). Peptide therapies: Clinical practice frequently asked questions.

Texas Board of Nursing. (2026). APRN practice frequently asked questions.

Texas Legislature. (2026a). Texas Occupations Code Chapter 157: Authority of physician to delegate certain medical acts.

Texas Legislature. (2026b). Texas Occupations Code Chapter 201: Chiropractors.